Jason J. Luke

Cancer Immunotherapy Principles and Practice

Ke Liu, Pedro Romero, Patricia A. Young, 2018 .

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

Hussein Tawbi, Aliya N. Husain, L. Heinzerling, 2016, Journal of Immunotherapy for Cancer.

Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma

Gary K. Schwartz, Douglas R. Adkins, C. Antonescu, 2015, Cancer Chemotherapy and Pharmacology.

The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

Riyue Bao, J. Luke, M. Alegre, 2018, Science.